Quintrio
Home

Stock overview

InMode Ltd. Ordinary Shares

INMD

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.

Last trade $12.87
Day change -$0.28 (-2.13%)
Day range $12.84 – $13.21
Volume 319,483
Market cap $757M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$756.71M
Price / earnings
7.95×
Price / book
2.58×
Price / sales
3.27×
EV / sales
2.99×
EV / EBITDA
7.36×

Profitability

Earnings per share
$1.66
Return on assets
28.24%
Return on equity
32.42%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0×
Current ratio
9.05×
Quick ratio
8.62×
Cash ratio
1.77×

Cash flow

Price / cash flow
7.73×
Price / free cash flow
7.74×
Free cash flow
$97.81M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for INMD, quarterly periods
Line itemQ1 FY2021 Mar 31, 2021Q4 FY2020 Dec 31, 2020Q3 FY2020 Sep 30, 2020Q2 FY2020 Jun 30, 2020Q1 FY2020 Mar 31, 2020Q4 FY2019 Dec 31, 2019Q3 FY2019 Sep 30, 2019
Revenue$65.52M$75.19M$59.71M$30.77M$40.44M$47M$40.01M
Cost of revenue$10.08M$10.58M$9.4M$4.7M$6.18M$6.05M$5.05M
Gross profit$55.45M$64.61M$50.32M$26.07M$34.26M$40.96M$34.96M
Selling, general and administrative$26.37M$26.91M$25.07M$16.15M$24.82M$21.39M$17.65M
Research and development$2.3M$2.26M$1.96M$1.82M$3.43M$1.59M$1.33M
Total operating expenses$28.67M$29.17M$27.03M$17.97M$28.25M$22.98M$18.98M
Operating income$26.77M$35.44M$23.29M$8.11M$6M$17.98M$15.98M
Interest expense———————
Income before taxes$26.82M$36.67M$24.09M$8.74M$6.63M$19.14M$16.46M
Income taxes$69K$598K$207K$161K$141K$165K$267K
Net income$26.75M$36.07M$23.88M$8.58M$6.49M$18.97M$16.19M
Net income attributable to common shareholders$26.64M$36.11M$23.9M$8.59M$6.43M$19.04M$16.19M
EBITDA$26.89M$35.44M$23.4M$8.21M$6.1M$17.98M$16.06M
Basic earnings per share$0.34-$0.05$0.33$0.12$0.10-$0.46$0.27
Diluted earnings per share$0.32-$0.04$0.28$0.10$0.07-$0.35$0.21

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

Body Contouring Devices Market Expands as Non-Invasive Technology Reaches Untapped Male Demographic

The global body contouring devices market is expected to grow from $2.41 billion in 2025 to $8.82 billion by 2035, with a CAGR of 13.84%. Non-invasive treatments dominate with 78.4% market share, driven by rising obesity rates and increasing demand for non-surgical aesthetic procedures. The U.S. market alone is projected to reach $2.74 billion by 2035. Key growth drivers include expanding male demographics, multi-modal technology platforms, and rising social media influence on aesthetic awareness.

GlobeNewswire Inc.

Energy-Based Aesthetic Devices Market Research Report 2026-2031: Advancements in Laser and RF Systems, Rising Consumer Demand and Geographic Expansion Accelerate Revenue Opportunities

The Energy-Based Aesthetic Devices Market is projected to grow from USD 7.03 billion in 2025 to USD 11.80 billion by 2031 at a CAGR of 9.02%. Growth is driven by increased demand for hair removal treatments, med-spa expansion, minimally invasive procedures, and AI integration. Laser-based technology dominates the market, with North America leading globally. Key challenges include rising health and wellness awareness and high device costs.

Benzinga

Deal Dispatch: Musk Merger Talk, LIV Golf Stakes, And A Flurry Of M&A From AI To Athleisure

Major M&A activity spans multiple sectors: Elon Musk reportedly weighs merging SpaceX, Tesla, and xAI; C3.ai is in merger talks with Automation Anywhere; Anta Sports acquires 29% stake in Puma for €1.51 billion; Steel Partners offers $1.1 billion for InMode controlling stake; LIV Golf seeks minority investors for team stakes; and First Brands Group founders face fraud charges related to bankruptcy.

Benzinga

Steel Partners Targets InMode, Citing Stock Underperformance

Steel Partners Holdings has made an unsolicited proposal to acquire a controlling 51% stake in InMode Ltd. at $18 per share, representing a 29% premium to the stock's January 23 closing price. The acquisition proposal cites InMode's poor stock performance (negative 19.18% over one year), repeated guidance cuts (seven reductions in nine quarters), and inefficient capital allocation despite holding $532.3 million in cash with no debt. Steel Partners, already a 1.3% shareholder, stated it will pursue a binding offer directly to shareholders if discussions don't progress.

Benzinga

InMode to Participate in Upcoming Investor Conferences

InMode Ltd. announced participation in two investor conferences in August 2025, including the Needham Virtual MedTech & Diagnostics Conference and Canaccord 45th Annual Global Growth Conference, featuring presentations by their CEO and CFO.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Oct 1, 20212-for-1forward split